← Eichor
Study identifier: NCT05379153 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

Condition: Anatomic Stage 0 Breast Cancer AJCC v8 · Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage IA Breast Cancer AJCC v8  ·  Sponsor: Alliance for Clinical Trials in Oncology

PhasePhase 3
Planned participants250
Who can joinFemale, 22 Years to no upper limit
Healthy volunteersNo

About this study

This phase III trial tests whether vaginal fractional CO2 laser therapy works in treating vaginal dryness in breast cancer survivors. Vaginal dryness can be commonly experienced with normal aging, with menopause, or come about from medications used to treat breast cancer such as chemotherapy or endocrine therapies like tamoxifen or aromatase inhibitors. Vaginal fractional CO2 laser therapy may help reduce vaginal dryness.

This description comes directly from the study's public registry record.

Talk to the study team

Maryam Lustberg, MD, MPH  ·  (203) 785-4095  ·  Maryam.lustberg@yale.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Trinity Health IHA - Obstetrics and Gynecology West ArborAnn Arbor, Michigan, United StatesRecruiting
Ohio State University Comprehensive Cancer CenterColumbus, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05379153